Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution

Transfusion Medicine

Volumn 14, Issue 4, 2004, Pages 289-295

  Van Rhenen, D J ^a   Gulliksson, H ^b   Cazenave, J P ^c   Pamphilon, D ^d   Davis, K ^e   Flament, J ^f   Corash, L ^g  

^a Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d Bristol Inst for Transfus Sciences   (United Kingdom)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BAXTER HEALTHCARE CORPORATION   (United States)

^g CERUS CORPORATION   (United States)

Author keywords

Haemostasis; Platelet additive solution; Platelet transfusion

Indexed keywords

DRUG ADDITIVE; T SOL;

ADOLESCENT; ARTICLE; BLOOD COMPONENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 4043137199     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2004.00516.x     Document Type: Article

References (16)

1. Bertolini, F., Rebulla, P., Riccardi, D., Cortellaro, M., Ranzi, M.L. & Sirchia, G. (1989) Evaluation of platelet concentrates prepared from buffy coats and stored in glucose-free crystalloid medium. Transfusion, 29, 605-609.
2. Davis, K.B., Slichter, S.J. & Corash, L. (1999) Corrected count increments and platelet recoveries as measures of post-transfusion platelet response: problems and a solution. Transfusion, 39, 586-592.
3. Eriksson, L., Kristensen, J. & Olsson, J. (1996) Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coats and apheresis. Vox Sanguinis, 70, 69-75.
4. Gmur, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of a stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet, 338, 1223-1226.
5. Gulliksson, H., AuBuchon, J.P., Vesterinen, M., Sandgren, P., Larsson, S., Pickard, C.A., Herschel, I., Roger, J., Tracy, J.E. & Langweiler, M. (2002) Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sanguinis, 82, 131-136.
6. Gulliksson, H., Eriksson, L., Hogman, C.F. & Payrat, J.M. (1995) Buffy coat derived platelet concentrates prepared from half-strength citrate CPD and CPD whole blood units. Comparison between three additive solutions. Vox Sanguinis, 68, 152-159.
7. Heddle, N.M., Kalma, L., Singer, J., Richards, C., Fedak, P., Walker, I. & Kelton, J.G. (1994) The role of plasma from platelet concentrates in transfusion reactions. The New England Journal of Medicine, 331, 625-628.
8. Knutson, F., Alfonso, R., Dupuis, K., Mayaudon, V., Lin, L., Corash, L. & Hogman, C.F. (2000) Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sanguinis, 78, 209-216.
9. Liang, K.Y. & Zeger, S.L. (1986) Longitudinal data analysis using generalized linear models. Biometrika, 73, 13-22.
10. Lin, L., Cook, D.N., Wiesehahn, G.P., Alfonso, R., Behrman, B., Cimino, G.D., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Fang, Y.M., Hanson, C.V., Hearst, J.E, Lin, C.Y., Londe, H.F., Metchette, K., Nerio, A.T., Pu, J.T., Reames, A.A., Rheinschmidt, M., Tessman, J., Isaacs, S.T., Wollowitz, S. & Corash, L. (1997) Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion, 37, 423-435.
11. van Rhenen, D., Gulliksson, H., Cazenave, J.P., Pamphilon, D., Ljungman, P., Klüter, H., Vermeij, J., Kappers-Klunne, M., de Greef, G., Laforet, M., Liouvre, B., Davis, K., Marblie, S., Mayaudon, V., Flament, J., Conlan, M., Lin, L., Metzel, P., Buchholz, D. & Corash, L. (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the EUROSPRITE 3 trial. Blood, 101, 2426-2433.
12. van Rhenen, D.J., Vermeij, J., Kappers-Klunne, M.C. & Payrat, J.M. (1995) Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell reduced platelet concentrates obtained from half strength CPD pooled buffy coats. Transfusion, 35, 50-53.
13. van Rhenen, D.J., Vermeij, J., Mayaudon, V., Hind, C., Lin, L. & Corash, L. (2000) Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sanguinis, 79, 206-214.
14. Slichter, S.J. (2002) Intercept platelets provide effective hemostasis and count increments: comparison to conventional platelets in 2 phase III clinical trials. Hematology Journal, 3 (Suppl. 1), 172.
15. TRAP Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The New England Journal of Medicine, 337, 1861-1869.
16. de Wildt-Eggen, J., Nauta, S., Schrijver, J.G., Marwijk van Kooy, M., Bins, M. & van Prooijen, H.C. (2000) Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomised study. Transfusion, 40, 398-403.